Vaccine provides protection against five diseases

Infanrix-IPV+Hib is a multi-component vaccine that provides protection against diphtheria, tetanus, pertussis, polio and invasive diseases caused by Haemophilus influenzae type b.

Infanrix-IPV+Hib is appropriate for the active immunisation of children from age two months.

Primary immunisation is a course of two or three doses, separated by a minimum of four weeks between each dose. A booster dose should be given at least six months after the last priming dose, preferably between 11 and 13 months of age. The vaccine is not suitable for children over 36 months of age.

Further information: GlaxoSmithKline, Stockley Park West, Uxbridge, Middlesex UB1 1BT. Tel: (0800) 221441.
Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

SGLT2 inhibitors summarised in new MIMS table

SGLT2 inhibitors summarised in new MIMS table

Prescribers can quickly compare key features and benefits...

Proposed withdrawal of bipolar disorder treatment revoked

Proposed withdrawal of bipolar disorder treatment revoked

The manufacturer of first-line bipolar disorder treatment...